XELJANZ (tofacitinib)

**Product type:** Human Prescription Drug

**Active ingredient:** TOFACITINIB CITRATE

**Strength:** 11 mg/1

**Dosage form:** Tablet, Extended Release

**Route:** Oral

**Labeler:** U.S. Pharmaceuticals

**Marketing category:** NDA (NDA208246)

**Pharmacologic class:** Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]